Outpatient management of established bronchopulmonary dysplasia: An update.
Bronchopulmonary dysplasia
Chronic lung disease
NICU graduates
Journal
Seminars in perinatology
ISSN: 1558-075X
Titre abrégé: Semin Perinatol
Pays: United States
ID NLM: 7801132
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
medline:
27
11
2023
pubmed:
1
10
2023
entrez:
30
9
2023
Statut:
ppublish
Résumé
As the incidence of infants with bronchopulmonary dyspasia (BPD) has continued to rise, so has their rate of survival. Their medical management is often complex and requires the use of numerous therapies such as steroids, bronchodilators, diuretics and modalities to deliver supplemental oxygen and positive pressure. It also requires multi-disciplinary care to ensure adequate growth and to optimize neurodevelopmental outcomes. This review aims to discuss the most widely used therapies in the treatment of patients with established BPD. The focus will be on ongoing outpatient (post-neonatal intensive care) management of children with BPD. Since many of the mentioned therapies lack solid evidence to support their use, more high quality research, such as randomized controlled trials, is needed to assess their effectiveness using defined outcomes.
Identifiants
pubmed: 37777461
pii: S0146-0005(23)00123-4
doi: 10.1016/j.semperi.2023.151820
pii:
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
151820Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.